
Technical analysis of BioNTech SE (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
BioNTech SE is a German pharmaceutical company engaged in the development and commercialization of immunotherapies, with a focus on mRNA vaccines and oncology drugs. The company's pipeline includes the BNT162 vaccine for SARS-CoV-2 and multiple drug candidates in clinical trials for the treatment of solid tumors and infectious diseases.
Description generated automatically from public sources; it may be inaccurate or out of date.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the BNTX analysis.
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
How is BioNTech SE analysed technically?
Technical analysis of BioNTech SE is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for BioNTech SE?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to BioNTech SE?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to BioNTech SE it helps frame the technical structure of the historical chart and is not a forecast.
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.